---

Retinoblastoma: changing trend in a tertiary eye centre

---

Original Article

Author Details : Hom Bahadur Gurung, Ben Limbu, Ang Jangmu Lama*, Hamish Brown, Rohit Saiju

Volume : 5, Issue : 2, Year : 2019

Article Page : 252-256

https://doi.org/10.18231/j.ijceo.2019.059

Suggest article by email

Get Permission

---

Abstract

Purpose: Retinoblastoma though a rare disease is the most common intraocular malignancy in the paediatric population. The age of presentation, clinical picture and modes of treatment has been changing with time in developing countries. The purpose of this study is to evaluate the changing trend and know our current status on retinoblastoma.
Materials and Methods: Five years retrospective study of retinoblastoma patients at a tertiary eye centre in Kathmandu.
Results: Seventy-four eyes of 62 patients fulfilled the inclusion criteria. There was equal gender distribution. Eighty percent had unilateral retinoblastoma while twenty percent had bilateral retinoblastoma. Unilateral cases presented late (32.23 months) while bilateral cases presented earlier (19 months). 71% patients presented with leukocoria while only 11% presented with proptosis. Sixty-four eyes underwent destructive procedure (60 enucleation and 4 exenteration) and 10 eyes were managed with LASER.
Conclusion: Retinoblastoma patients are presenting earlier with leukocoria as common mode of presentation. Eye saving management of retinoblastoma are in rising trend in recent years.

Keywords: Retinoblastoma, Leukocoria, Enucleation, Nepal.

How to cite : Gurung H B, Limbu B, Lama A J, Brown H, Saiju R, Retinoblastoma: changing trend in a tertiary eye centre. Indian J Clin Exp Ophthalmol 2019;5(2):252-256

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.